Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zydus Cadila Group
DescriptionHypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor
Molecular Target Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
Mechanism of ActionHypoxia-inducible factor prolyl hydroxylase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today